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Abstract. In this paper we present applications of the ACGT Master Ontology 
(MO) which is a new terminology resource for a transnational network provid-
ing data exchange in oncology, emphasizing the integration of both clinical and 
molecular data. The development of a new ontology was necessary due to prob-
lems with existing biomedical ontologies in oncology. The ACGT MO is a test 
case for the application of best practices in ontology development. This paper 
provides an overview of the application of the ontology within the ACGT pro-
ject thus far.   
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1   Introduction 
Over the last decade the amount of data on cancers and their treatment has exploded 
due to advances in research methods and technologies. Recent research results have 
changed our understanding of fundamental aspects of cancer development at the mo-
lecular level. Nevertheless, irrespective of the fact that huge amounts of multilevel 
datasets (from the molecular to the organ and individual levels) are becoming avail-
able to biomedical researchers, the lack of a common infrastructure has prevented 
clinical research institutions from being able to mine and analyze disparate data 
sources efficiently and effectively. As a result, very few cross-site studies and multi-
centric clinical trials are performed, and in most cases it is not possible to seamlessly 
integrate multi-level data. Moreover, clinical researchers and molecular biologists 
often find it hard to take advantage of each other’s expertise due to the absence of a 
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cooperative environment which enables the sharing of data, resources, or tools for 
comparing results and experiments, and of a uniform platform supporting the seam-
less integration and analysis of disease-related data at all levels [1]. This situation 
severely jeopardizes research progress and hinders the translation of research results 
into benefits to patients.  
The Advancing Clinico-Genomic Trials on Cancer (ACGT) integrated project aims 
to address this obstacle by setting up a semantic grid infrastructure in support of 
multi-centric, post-genomic clinical trials [2]. This system is designed to enable the 
smooth and prompt transfer of laboratory findings to the clinical management and 
treatment of patients. Obviously, this goal can only be achieved if state-of-the-art 
semantic technologies are part of the IT environment. In order to meet this goal, the 
ACGT project needed an ontology to be utilized in the context of its selected Local-
As-View (LAV) data integration strategy [3]. In such a strategy the ontology plays the 
role of a global schema to which all local schemata are mapped, so that all their 
mapped equivalents are subsumed by the global schema. This requires that the global 
schema (i.e. the ontology) be sufficiently generic as to cover not only terminology, 
but also the meaning of all local schema constructs. The ACGT project achieves the 
semantic integration of heterogeneous biomedical databases through a service ori-
ented, ontology driven mediator architecture that makes use of the ACGT-MO [4, 5]. 
The new terminology resource which underlies this integration rests upon a thorough 
review and critical assessment of the state of the art in semantic representation of 
cancer research and management.  
2   Pre-existing Ontologies and Terminologies 
Cancer has been a focus of interest in biomedical research for a very long time. As a 
result of this long history, a number of terminological resources exist that are of rele-
vance to ACGT. In order to prevent redundancy, the project undertook a very detailed 
review. We will illustrate this selection process by focusing on two potential resources 
that did not meet our criteria of excellence, and hence were either not used in ACGT, 
or were used after considerable alteration. We will further mention two general bio-
medical resources selected for integration in the ACGT terminological network.   
When considering the development of an ontology-based information-sharing sys-
tem for the cancer domain of the sort used by ACGT, the National Cancer Institute 
Thesaurus (NCIT) is a terminology resource of obvious relevance [6] Yet, there are a 
number of drawbacks preventing the use of the NCIT as semantic resource of the 
ACGT project, in part because its formal resources are too meager for our purposes, 
with only a fraction of NCIT terms being supplied with formal definitions of the sort 
required by its official description logic (DL) framework. The NCIT contains only 
one relation, namely the subtype relation (is_a), as contrasted with the plurality of 
formally defined relations included, for example, within the OBO Relation Ontology 
[7]. Further, the NCIT is marred by a number of problems in its internal structure and 
coverage [8], including problems in the treatment of is_a. For a quick illustration of 
the inadequate treatment of is_a in the reviewed version of NCIT. let us consider the 
NCIT class Organism, which includes among its subtypes OtherOrganismGroupings; 
with this we have OtherOrganismGroupings is_a Organism [6]. Given the formal 
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definition of the subtype relation this is clearly wrong; groupings of organisms are not 
themselves organisms.   
Another resource that has the aura of indispensability in a domain dealing with 
gene array data is the Microarray and Gene Expression Data (MGED) ontology [9]. 
Yet, even this highly used resource shows considerable deficiencies, including infor-
mal is_a relations. The inconsistency becomes obvious when the textual definitions – 
which are an asset to MGED – are taken into account: According to the MGED  
ontology Host is a subclass of EnvironmentalHistory. It is obvious that this cannot be 
a formal is_a relation. Taking a close look reveals an astonishing incoherence here: 
The definition of Host is: “Organisms or organism parts used as a designed part of the 
culture (e.g., red blood cells, stromal cells)” [9]. The definition of EnvironmentalHis-
tory reads as follows: “A description of the conditions the organism has been exposed 
to that are not one of the variables under study” [9]. The thesis that an organism or 
organism part is a description clearly involves a crude category mistake (the confu-
sion of use and mention). For some portions of the ACGT domain, however well-built 
and well maintained ontologies with high usability could be identified and reused 
within ACGT. This, as a matter of fact, applies both to the Foundational Model of 
Anatomy (FMA) [10] and the Gene Ontology (GO) [11] since they both fulfill the 
requirements on coherence and theoretical rigor specified in [12].   
Most of the current ontologies for life sciences start from terminology appearing in 
documentation systems as data and pertaining to the “subject matter” of the research 
carried out, such as concepts about the human body, diseases and microbiological 
processes. However, the data kept in the systems ACGT aims at supporting also per-
tain to the scientific processes of observation, measurement and experimentation 
together with all contextual factors. A model for integrating that data must include 
this aspect. The CIDOC CRM (ISO21127, [13]) is a core ontology originally devel-
oped for schema integration in the field of documenting the historical context and 
treatment of museum objects, including a generic model of scientific processes. Some 
concepts and relations of the latter were reused and refined for the ACGT MO. 
Effectively, developing a new ontology was imperative, since no single ontology 
or set of ontologies had the respective coverage and logical consistency.  
3   The ACGT Master Ontology 
3.1   Technical Details of the ACGT MO 
The intention of the ACGT MO [4] is to represent the domain of cancer research and 
management in a computationally tractable manner. As such, we regard it as a domain 
ontology. The initial version of the ACGT MO that was made public on the internet 
consists of 1300 classes. The ontology was built, and is being maintained, using the 
Protégé-OWL open-source ontology editor [14]. It is written in OWL-DL [15] and 
presented as an .owl file. The ACGT MO not only represents classes as linked via the 
basic taxonomical relation (is_a), but connects them via other semantic relations 
called “properties” in OWL terminology. The OBO Relation Ontology (RO) [7] has 
been used as a basis in this regard, as RO has been specifically developed to account 
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for relations in biomedical ontologies [16]. Some properties of scientific observation 
were taken from the CIDOC CRM [13]. 
3.2   Methodology 
The ACGT MO has been developed in close collaboration with clinicians utilizing 
existing Clinical Report Forms (CRFs), which were used to gather documentation on 
the universals and classes in their respective target domains, and to understand the 
general semantics of form-based reporting of clinical observation.  All versions of the 
ontology have been reviewed by clinical partners who have proposed changes and 
extensions according to needs. In this process the problem of handling an ontology 
with more than 1300 classes for clinical users became apparent. Providing tools to 
examine the ontology in user-friendly ways emerged as inevitable. Yet, to ensure com-
prehensiveness of the representation of relevant portions of reality it was found neces-
sary to go beyond the CRFs and the documentation provided by the clinical project 
partners. The latter governed the development of the leaf nodes of the ACGT MO, but 
we had to identify classes for a middle layer of the representation in order to ensure 
that the ontology provided the necessary reasoning support. Therefore, standard litera-
ture and standard classification systems were used, e.g. [17, 18, 19]. In order to provide 
a consistent and sound representation, the ACGT MO employs the resources of an 
Upper Ontology, which does not represent domain specific knowledge, but consists of 
classes that are generic and abstract [20]. The ACGT MO is based on Basic Formal 
Ontology (BFO) [21] which has proven to be highly applicable to the biomedical do-
main [22], and is now providing the advantage of common guidelines for ontology 
building to a multiplicity of research groups and organizations, 
It is a well-documented fact that well-built, coherent ontologies tend to be hard to 
understand for clinical users [23]. An is_a hierarchy based on BFO puts kinds of 
processes and kinds of objects on quite distant branches. The clinician should, never-
theless, have these associations readily available on the screen. We therefore proposed 
that the basis for these tools should be a viewing mechanism that should reflect the 
terms typically appearing together in particular clinical contexts, while the full ontol-
ogy was running behind the scenes. The necessary associations may be found and 
activated by tracking the workflows commonly used in computer applications serving 
clinical practice. In the following we present several specific techniques and work 
styles that were employed in the development of the ACGT MO.   
Lassila et al. [24] categorized ontologies according to the amount of information 
they contain. Their classification ascribes the term “ontology” to nearly everything 
that is at least a finite controlled vocabulary with unambiguous interpretation of 
classes and term relationships and with strict hierarchical subclass relationships be-
tween classes. We disagree with this overly liberal terminological practice. Ontolo-
gies that meet more elaborate criteria, and contain a much richer internal structure 
were dubbed “heavyweight” and differentiated from so-called “lightweight” ontolo-
gies [25]. Among the criteria mentioned for “heavyweight ontologies” are, besides the 
subtype relation discussed above, also the presence of properties, value restrictions, 
general logical constraints, and disjoints. The ACGT MO has been designed, in this 
respect, to be to a heavyweight ontology. A basic principle of ontology development 
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is that ontologies include only classes (types, universals) but not instances (tokens). 
Hence the ACGT MO does not include representations of real world instances but 
only of universals. One of the gold standards to be followed in order to ensure a 
proper structure of the taxonomy of universals, is the use of a formal subtype relation 
and the avoidance of the informal is_a relations mentioned above. The subtype rela-
tion (is_a) is formally defined as follows: A is_a B if and only if all instances of A are 
also instances  of B.  
In general, we embrace the thesis that a properly constructed ontology should steer 
clear of a taxonomical tree that allows multiple parent classes for the same child class 
(i.e. one child that inherits from multiple parents). The central aim is to avoid 
polysemy that often results from multiple inheritances. In the ACGT MO we com-
pletely avoided multiple inheritance.   
Another problematic case that can be found in a number of medical databases,  
terminologies and even “ontologies,” is the presence of so called Not Otherwise 
Specified (NOS) classes, e.g. “Brain Injury Not Otherwise Specified” or classes like 
“UnknownX” (“UnknownAffiliation”). Only recently havea number of revisions of 
SNOMED CT [26, 27] led to the deactivation of concepts involving the qualifier NOS 
such as 262686008 Brain injury NOS (disorder) and 162035000 Indigestion symptom 
NOS (finding). This demonstrates an increasing realist orientation in SNOMED CT. 
Already Cimino in his famous “Desiderata” essay [28] had counseled against the use 
of NOS and similar qualifiers. “Universals” of this kind do not, in fact, have any in-
stances of their own; rather, they merely hint at a lack of data or knowledge. The 
alleged instances of those universals do not exhibit any shared properties, at least not 
necessarily. Therefore, we avoided such classes in the ACGT MO. The review of pre-
existing biomedical ontologies targeting the ACGT domain led to the decision to re-
use the FMA and the GO. Furthermore, some existing medical classifications and/or 
controlled vocabularies have been, or will be, slightly modified and added to the on-
tology. An example of this type is the TNM system [19].  
4   Database Integration Process 
The ACGT Semantic Mediation Layer (ACGT-SM) comprises a set of tools and re-
sources that work together to serve processes of Database Integration and Semantic 
Mediation. The ACGT-MO is a core resource of this system, acting as Global Schema 
– i.e. a global framework for semantic homogenization – providing the formalization 
of the domain knowledge needed to support a variety of applications oriented towards 
clinical research and patient care. The ACGT-SM follows a Local-as-View Query 
Translation approach in order to cope with the problem of database integration. This 
means that data is not actually integrated, but is made accessible to users via a virtual 
repository. This repository represents the integration of the underlying databases, and 
the ACGT-MO acts here as database schema, providing resources for formulation of 
possible queries. The virtual repository has the shape of an RDF database, and the 
language selected for performing queries is SPARQL [29].  
The ACGT-SM comprises different tools addressing different problems, such as 
schema level heterogeneities and instance level conflicts both at the query and data 
levels. These tools are designed as independent web services that collaborate in the 
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mediation process and are coordinated bythe Semantic Mediator. The system also 
includes a tool devoted to aid in the process of building mappings. This mapping tool 
uses the ACGT-MO, and is based on a graphical visualization of its structure. The 
users of this mapping tool navigate the ACGT-MO and an underlying database 
schema in order to mark the entities that are semantically equivalent. The architecture 
of this system is shown in Figure 1. 
  
Fig. 1. ACGT Semantic Mediator Layer architecture 
The ACGT-SM exposes its data services using an OGSA-DAI [30] web based in-
terface. The OGSA-DAI middleware allows easy access and integration of data via 
the grid. However, no grid infrastructure is needed to access these services. The 
ACGT-SM offers two main services, namely 1) to launch a query, and 2) to browse 
the schema. The latter shows a subset of the ACGT-SM underlying RDF schema. 
This subset is built taking into consideration the user profile.  
This software system has been tested with clinical relational and image databases 
[31], obtaining promising results. Currently the consortium is developing a final user 
query tool, with the aim of helping non technical users in the processes of building 
and launching queries.  
5   Exploitation of the Ontology in a Clinical Trial Management  
     System 
The integration of existing data sources via the mediator is the general policy of the 
ACGT project. Yet the ultimate goal of ontology-based information management is to 
enable the direct integration of semantically consistent data created in different envi-
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ronments (e.g. clinical research, laboratory data, public health data). ACGT aims to 
provide solutions that demonstrate the possibility of creating data in an ontology-
governed way. To explore this approach, an Ontology-based Trial Management Sys-
tem (ObTiMA) is under development that enables those who undertake clinical trials 
to set up patient data management systems with comprehensive metadata by using the 
ACGT-MO [32]. This allows seamless integration of data collected in these systems 
into the ACGT mediator architecture. The main components of ObTiMA are the Trial 
Builder and the patient data management system. The Trial Builder allows a trial 
leader to define the master protocol, the Case Report Forms (CRFs) and the treatment 
plan for the trial in a way that is both semantically compliant with the ACGT MO and 
user-friendly. From these definitions, the patient data management system can be set 
up automatically. The data collected in the trial is stored in trial databases whose 
comprehensive metadata has been rendered from the start in terms of the ACGT-MO. 
The data can thus be seamlessly integrated through OGSA-DAI services [30] into the 
mediator architecture. Trial databases with comprehensive ontological metadata and 
the OGSA-DAI services are both automatically set up from the definitions made by 
the trial chairman in the Trial Builder 
In the following, we briefly describe how the Trial Builder allows the clinician to 
define all information needed to make integration possible. In setting up a trial, clini-
cians want to focus on the user interfaces and to adapt them to the specific workflow 
of the clinical trial planned. They do not wish to be concerned with theoretical aspects 
and design principles of databases or ontological metadata. Therefore, in ObTiMA, 
the trial leader defines both, by creating the CRFs for the intended trials. He is as-
sisted by ObTiMA in defining the questions on the CRFs, the order in which the ques-
tions will be queried, and constraints on the answer possibilities. Creating a question 
on the CRF is supported by simply selecting appropriate terms from the ACGT MO. 
For example, assuming that the clinician wants to collect all information on a pa-
tient’s gender. He observes that a relation between the classes “Patient” and “Gender” 
exists in ACGT MO. In creating the corresponding question, he simply has to choose 
the class Gender. The attributes required in order to create the question on the CRF 
are then determined very easily. E.g. as answer possibilities for the question the val-
ues Male, Female, and AmbiguousGender are suggested, because the class Gender is 
defined as an enumeration in the ontology containing these values and a multiple 
choice question is subsequently automatically created on the CRF.   
This procedure implements the semantics of the ontology in the CRFs in an  
automatic fashion.  
With the aim of setting up the appropriate database for storing the data, the follow-
ing attributes are needed for each question: the question itself, the data type of the 
answer and optionally possible data values, range constraints and measurement units. 
These attributes will as far as possible be determined automatically from the path the 
trial leader has selected, but can later be changed according to need and experience of 
what works best. This process leads to the possibility of lessons learned in integration 
of the data collected in the clinical trial at hand to be incorporated into the semantics 
of the ontology. In this way, the ontology itself improves in reflection of advances 
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made by the researchers using it. Through the integration of the ACGT-MO into Ob-
TiMA, data sharing between clinical trials becomes possible. This is necessary to 
leverage the collected data for further research for example in the creation of cross-
trial meta-analyses.   
 
Fig. 2. The ObTiMA ontology viewer 
We are aware that this ambitious enterprise requires tools to overcome the gap be-
tween clinical practice and biomedical reality representation. Even if an ontology 
provides natural language definitions for its entities and relationships (in order to 
make them human understandable) they are still defined in a way that is not based on 
practical or clinical perceptions of reality. In order to meet this desideratum, the Trial 
Builder provides an application-specific view on the ontology, a view that is meant to 
assist clinicians engaged in clinical practice or clinical trial management.  
Recent studies showed that, under three different scenarios, the accuracy of SNOMED 
coding is only slightly over 50 % [33, 34]. One additional potential advantage of ObTiMA 
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is that it may help put an end to some of the problems currently faced by those using 
coding techniques to map clinical data unto biomedical terminologies.  
6   Conclusions 
The ACGT project provides a novel terminological resource for cancer research and 
management. It has long been recognized that an obvious application for an ontology 
resource is to provide a stable common schema for a mediation system such as the 
one that serves integration across the ACGT network. ACGT has addressed also an-
other problem which is to provide more efficient and reliable tools for coding of clini-
cal data by providing an ontology-driven Clinical Trial Management system which 
aids the clinician in collecting the data in a way compliant with the ontology.  
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